Arthritis Research UK Introduces IBM Watson-Powered 'Virtual Assistant' to Provide Information and Advice to People with Arthritis

IBMArthritis Research UK and IBM (NYSE: IBM) have announced the development of a Watson-powered 'virtual personal assistant' to provide information and advice to people living with arthritis. The charity has teamed up with IBM to ensure people seeking help will have access to personalised information from the Arthritis Research UK website, delivered in a form that feels like a natural conversation. The service will be accessible on mobile phones and computers, without the need to download an app. There are currently 300 people with arthritis helping Arthritis Research UK to test and feedback before it is launched publicly on the charity’s website later this year.

For the millions of people living with the lifelong impact of all kinds of arthritis and musculoskeletal conditions, finding an answer to questions about their condition can be a challenge. Arthritis affects people in different ways, so for some turning to the internet and sorting through pages of conflicting advice can be daunting and confusing. Every year, Arthritis Research UK's website receives thousands of personal questions about the impact arthritis has on day to day life, symptoms and treatment options.

By tapping into IBM's Watson Conversation API, the charity has found an innovative way for people with arthritis to quickly and easily get answers to questions as soon as it pops into their head - no matter where they are or the time of day. This new service will mean that for the first time Arthritis Research UK will be able to provide every person in the UK seeking information about arthritis, immediate access to the best and most accurate information tailored to them. It will be supported by the charity’s information and enquiries line, where a team will be on hand to help answer detailed or complex questions.

Liam O'Toole, Chief Executive Officer at Arthritis Research UK, said: "We know that there are millions of people in the UK living with arthritis whose lives are severely limited as they struggle with unanswered questions. We want to ensure that everyone has access to information and support, whenever and wherever they need it.

"We're really excited to be working with IBM Watson on this innovative new service that will enable us to have conversations with anyone seeking help, that we simply wouldn't be able to answer so quickly otherwise. We're confident that this new virtual assistant will help more people push back the ways arthritis limits their lives."

The digital personal assistant was developed over five months using the charity’s 80 years of research based knowledge and expertise as well as advice from health care professionals, people with arthritis and IBM Watson cognitive computing experts. Over 350 people with arthritis have been involved during this time, to help develop, test and improve the tool. Initially, the service will be able to provide general information about arthritis and exercise that people can print out or save online.

In time, this knowledge base will grow to enable Arthritis Research UK to answer more questions - including those around diet and treatment options. As IBM Watson learns from each interaction, it will refine the information that is surfaced. Following this, Arthritis Research UK plans to leverage Watson cognitive voice input/output and location services to extend its capabilities, for example to understand questions delivered via speech (versus typed via a keyboard).

"Arthritis Research UK developed the Watson-powered digital personal assistant themselves, providing a terrific example of how IBM's open, cloud-based Watson development platform is making cognitive computing broadly accessible to organizations and individuals worldwide," said Cameron Brooks, IBM European Director for Watson in the Public Sector. "Further, Arthritis Research UK’s use of Watson APIs is a model for organizations thinking about how they might integrate cognitive computing into their services in order to positively impact the lives of people living with a serious health condition."

About Arthritis Research UK
Arthritis Research UK is the charity committed to ensuring people with arthritis are in control of their condition. We invest in breakthrough treatments, the best information and vital support for everyone affected by arthritis. We believe that by harnessing the power of exceptional science we can overcome the pain, isolation and fatigue arthritis causes, making everyday life better for all people with arthritis in the UK.

About IBM Watson Health
Watson is the first commercially available cognitive computing capability representing a new era in computing. The system, delivered through the cloud, analyzes high volumes of data, understands complex questions posed in natural language, and proposes evidence-based answers. Watson continuously learns, gaining in value and knowledge over time, from previous interactions. In April 2015, the company launched IBM Watson Health and the Watson Health Cloud platform. The new unit helps improve the ability of doctors, researchers and insurers to innovate by surfacing insights from the massive amount of personal health data being created and shared daily. The Watson Health Cloud can mask patient identities and allow for information to be shared and combined with a dynamic and constantly growing aggregated view of clinical, research and social health data.

Most Popular Now

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...

Virtual Reality Environment for Teens ma…

Social media. The climate crisis. Political polarization. The tumult of a pandemic and online learning. Teens today are dealing with unprecedented stressors, and over the past decade their mental health...

AI Predicts Tumor-Killing Cells with Hig…

Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies. Combined with additional algorithms...

Researchers Use Foundation Models to Dis…

Researchers at Mass General Brigham have harnessed the technology behind foundation models, which power tools like ChatGPT, to discover new cancer imaging biomarkers that could transform how patterns are identified...